Diasorin Molecular Sonsored Session: Unmasking the Silent Threat: Rapid Molecular Diagnostics for Fungal Sepsis and Detection of Candida auris
Includes a Live Web Event on 09/24/2025 at 10:45 AM (PDT)
Description:
This session is part of Sepsis Alliance Summit 2025.
This sponsored session explores the urgent clinical challenges of diagnosing fungal sepsis, with a focus on the rising threat of Candida auris (C. auris). It will highlight the limitations of conventional diagnostic methods in detecting fungal pathogens quickly and accurately, especially in critically ill patients. Advancements in molecular diagnostics, including rapid PCR and syndromic panels, are presented as transformative tools that offer broader pathogen coverage, faster time-to-result, and improved sensitivity. Special attention is given to the role of molecular testing in identifying C. auris colonization, which is crucial for outbreak control and infection prevention. The presentation will also outline the clinical and public health value of these innovations, from earlier antifungal therapy to potential cost savings and enhanced stewardship. Finally, we will look ahead to global surveillance efforts and treatment strategies, concluding with a call to action: rapid diagnostics are not just helpful; they’re lifesaving.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Session Supporter:
Sepsis Alliance gratefully acknowledges the support of this session provided by Diasorin: Molecular Diagnostics.
Siu Kei (Jacky) Chow, Ph.D., D(ABMM)
Clinical Laboratory Director
Multicare Health System Washington State
Dr. Siu Kei (Jacky) Chow, Ph.D., D(ABMM), is a distinguished Clinical Laboratory Director at MultiCare Health System in Tacoma, WA, with extensive expertise in microbiology and immunology. He holds a Ph.D. and M.S. from Albert Einstein College of Medicine, an M.S. in Bioengineering, and a B.S. magna cum laude in Bioengineering-Premed from the University of California, San Diego. Board-certified by the American Board of Medical Microbiology, Dr. Chow has over a decade of experience in clinical microbiology, including leadership roles overseeing laboratory operations across multiple hospitals and clinics. He has contributed significantly to infectious disease diagnostics, laboratory management, and public health initiatives, serving on various advisory committees and editorial boards. A prolific researcher and speaker, Dr. Chow has authored numerous publications and presented at prestigious conferences, advancing the field of clinical microbiology through innovative diagnostics and research.